Latest News for: mhra

Edit

MHRA Chair Professor Anthony Harnden: Bringing our strategy to life – listening, learning, and looking ahead (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 09 Oct 2026
Over the course of this blog series, we have deliberately created space for voices beyond the MHRA to challenge, reflect and help shape our thinking ... This series has brought together a rich set of perspectives from outside and within the MHRA.
Edit

MHRA Chair Professor Anthony Harnden: Bringing our strategy to life – listening, learning, and looking ahead (FSA - Food Standards Agency)

Public Technologies 09 Oct 2026
). Over the course of this blog series, we have deliberately created space for voices beyond the MHRA to challenge, reflect and help shape our thinking ... This series has brought together a rich set of perspectives from outside and within the MHRA.
Edit

Role of the Digital Mental Health Technology (DMHT) Working Group (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 09 Oct 2026
This was a collaborative project led by the MHRA in collaboration with National Institute for Health and Care Excellence (NICE) to clarify the regulation and evaluation of DMHTs that qualify as software as a medical device (SaMD).
Edit

Patient reported outcomes (PROs) resources for digital mental health technologies (DMHTs) (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 09 Oct 2026
MHRA guidance on clinical investigations clarify when clinical studies involving medical devices need to be reported to the MHRA as a clinical investigation ... event reporting obligations to the MHRA.
Edit

MHRA approves catumaxomab to treat cancer-related fluid build-up in the abdomen (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 07 Oct 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved catumaxomab (Korjuny) to treat malignant ascites in adults when standard treatment of their cancer is no longer feasible.
Edit

MHRA approves catumaxomab to treat cancer-related fluid build-up in the abdomen (FSA - Food Standards Agency)

Public Technologies 07 Oct 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved catumaxomab (Korjuny) to treat malignant ascites in adults when standard treatment of their cancer is no longer feasible.
Edit

Lord\u0026#039;s Mark Industries Advances UK \u0026amp; Allied Countries Expansion with MHRA Registration for IVD Portfolio

DNA India 06 Oct 2026
Lord ....
Edit

Government Response to the National Commission's Recommendations on the Regulation of AI in Healthcare. (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 06 Oct 2026
MHRA - Medicines and Healthcare products Regulatory Agency published this content on ...
Edit

Government backs recommendations of NHS doctors-led AI Commission (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 06 Oct 2026
Alongside the response, the MHRA is opening the call for applications for the third phase of AI Airlock, its regulatory sandbox for AI-enabled medical devices, with testing themes directly informed by the Commission's recommendations.
Edit

Lord’s Mark industries advances UK & allied countries expansion with MHRA registration for IVD portfolio

The Times of India 05 Oct 2026
Within days of announcing its MHRA registration for its AI-powered ... “Our recent MHRA registration for the Renalyx haemodialysis system opened an important door for us in the UK & Uk allied markets.
Edit

MHRA joins global regulators in call to advance alternatives to animal testing (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 01 Oct 2026
The MHRA has today joined international medicines regulators in a joint statement calling for alternatives to animal testing throughout the lifecycle of human medicines to be advanced and implemented, wherever and as soon as possible.
Edit

MHRA joins global regulators in call to advance alternatives to animal testing (FSA - Food Standards Agency)

Public Technologies 01 Oct 2026
The MHRA has today joined international medicines regulators in a joint statement calling for alternatives to animal testing throughout the lifecycle of human medicines to be advanced and implemented, wherever and as soon as possible.
Edit

Zepzelca® (lurbinectedin) in combination with atezolizumab approved by the MHRA as first-line maintenance therapy for extensive-stage small cell lung cancer in the United Kingdom (Immedica Pharma AB)

Public Technologies 01 Oct 2026
Press release - Zepzelca® (lurbinectedin) in combination with atezolizumab approved by the MHRA as first-line maintenance therapy for extensive-stage small cell lung cancer in the United Kingdom.
Edit

Lord’s Mark secures MHRA registration for dialysis device, plans UK expansion

The Economic Times 30 Sep 2026
Lord's Mark Industries Limited has successfully secured regulatory registration from the MHRA for ...
Edit

DIA and MHRA announce speaker line-up for inaugural global summit (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 30 Sep 2026
Aljadhey (Saudi Food and Drug Authority), Pamela Aung-Thin (Health Canada), Vincenza Trivigno (Swissmedic) and Adj Prof (Dr) Raymond Chua, (Health Sciences Authority, Singapore) together with top executive representatives from the MHRA.

Article Search

tools
×
×
×
×